![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, June 07, 2022 4:16:23 PM
OTCShotCaller
Bullish
07:58 AM
$RGBP
- Well folks it appears we've arrived! 100% PROOF Dr. Koos is on the right track with our Check-Point Inhibitor for treating Cancer!
Just out yesterday June 6, 2022, Oncologist Dr. Andrea Cercek at Memorial Sloan Kettering Cancer Center is interviewed on CNN regarding the results of a clinical trial on 14 patients with colorectal cancer treated with the Immunotherapy Drug Dostarlimab. All 14 patients had 100% disappearance of the rectal cancer within 24 weeks of treatment with little or no side effects.
youtube.com/watch?v=a0rbO3p...
Dostarlimab was developed by a Biotech by the name of Tesaro which was later bought by GlaxoSmithKline January 2019 for $5.1B. The results of the above study was published in The New England Journal of Medicine on June 5th that describes these historic results of all patents being cancer free after treatment.
beckersasc.com/gastroentero...
This is what I've mentioned here hundreds of times, i.e. we're entering into a Paradigm Shift in the Practice of Medicine.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM